2ⁿᵈ Edition of the Cancer R&D World Conference 2026

Scientific Sessions

Cancer Genomics and Epigenomics

This session highlights the intersection of genomic and epigenomic changes in cancer. It explores how mutations, copy number variations, and epigenetic modifications, such as DNA methylation and histone modifications, contribute to tumorigenesis. At the Cancer Research and Development Conference 2025, experts will discuss how next-generation sequencing and epigenetic profiling advances are enabling more precise cancer diagnostics and targeted therapies. The session will also address the role of cancer genome atlas data in identifying key biomarkers for personalized treatment strategies.

Related Sessions

Current Landscape and Future Directions of Oncology Research
Oncogenic Signaling Pathways and Therapeutic Targets
Emerging Biomarkers for Cancer Detection and Prognosis
Cancer Prevention and Early Detection Strategies
Immuno Oncology and Cell Based Therapies
Innovations in Immuno Oncology
Cytokine Modulation and Immune Adjuvants in Cancer Immunotherapy
Cancer Vaccines
CAR T Cell Therapy: Clinical Progress and Challenges
Next Generation Cell and Gene Therapies in Oncology
Liquid Biopsy and Circulating Tumor DNA (ctDNA) Diagnostics
Companion Diagnostics
Artificial Intelligence and Machine Learning in Precision Oncology
Next Generation Targeted Therapies: KRAS, HER2, BRAF, and NRAS
Overcoming Drug Resistance: Mechanisms and Solutions
Oncology Pipeline
Trends in Antibody Drug Conjugates (ADCs)
Launch of Novel mAb Products for Cancer Therapy